Local health departments prepare for approval of COVID-19 vaccine for younger children

As the Food and Drug Administration’s outside vaccine advisors met to decide whether to recommend approval of Pfizer's COVID-19 vaccine for children ages 5 to 11, doctors and health leaders watched for professional and personal reasons.